Elekta Neuro-Oncology Series #5: Dr. Arjun Sahgal - Brain Metastasis

**Trigger Warning**

Naman Julka-Anderson and Jo McNamara catch up with Dr. Arjun Sahgal to discuss his career, and the uses of radiosurgery for brain metastasis.

 

To use this podcast as CPD, look at these reflection points: 

1) read about the symptoms of a brain tumour: https://www.thebraintumourcharity.org/brain-tumour-signs-symptoms/adult-brain-tumour-symptoms/

2) reflect on the benefits of radiosurgery for people diagnosed with brain metastasis.

3) consider the impact of reduced access to radiosurgery could have on a a person living with beyond cancer and their loved ones / carers.

4) watch this video on the Elekta Gamma Knife Radiosurgery: https://www.youtube.com/watch?v=pxikNfTbtzw 

Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:

Elekta: https://www.elekta.com/

Elekta Gamma Knife Radiosurgery: https://www.elekta.com/patients/gamma-knife-treatment/

Leksell Gamma Knife Lightening: https://www.elekta.com/products/stereotactic-radiosurgery/leksell-gamma-knife-lightning/

The National Centre for Stereotactic Radiosurgery: https://www.gammaknife.org.uk/

The National Centre for Stereotactic Radiosurgery Videos on how to prepare for treatment: https://www.gammaknife.org.uk/treatment/videos

Brain Tumour Charity: https://www.thebraintumourcharity.org/brain-tumour-signs-symptoms/adult-brain-tumour-symptoms/

Brain Tumours Macmillan Cancer Support: https://www.macmillan.org.uk/cancer-information-and-support/brain-tumour

Therapeutic Role of Gamma Knife Stereotactic Radiosurgery in Neuro-Oncology (2020): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023953/

Characterization and commissioning of a Leksell Gamma Knife ICON system for framed and frameless stereotactic radiosurgery (2022): https://pubmed.ncbi.nlm.nih.gov/35064749/ Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial (2024): https://www.sciencedirect.com/science/article/pii/S0360301624000154?via%3Dihub 

FINAL RESULTS OF THE MGMT UNMETHYLATED ARM OF PARADIGM-2: A PHASE I STUDY OF OLAPARIB AND RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2023): https://academic.oup.com/neuro-oncology/article-abstract/25/Supplement_2/ii20/7264478?redirectedFrom=fulltext&login=true 

Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM) (2017): https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.2022 

Non-Cancerous Conditions Links:

The National Centre for Stereotactic Radiosurgery Other Conditions Treated: https://www.gammaknife.org.uk/conditions-treated/conditions

Elekta case stud on bilateral thalamotomy with Leksell Gamma Knife for Essential Tremor: https://www.elekta.com/medical-affairs/case-studies/case-study-bilateral-thalamotomy-with-leksell-gamma-knife-for-essential-tremor/

Gamma Knife radiosurgery for cerebral arteriovenous malformations: a systematic review and meta-analysis (2022): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160151/

Gamma Knife Radiosurgery For Brain Vascular Malformations: Current Evidence And Future Tasks (2019): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874113/ 

Gamma Knife Radiosurgery for Trigeminal Neuralgia : Review and Update (2022): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452385/

Arjun’s Research:

Hypofractionated stereotactic radiosurgery(HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery(SRS).

Yan M, Lee M, Myrehaug S, Tseng CL, Detsky J, Chen H, Das S, Yeboah C, Lipsman N, Costa LD, Holden L, Heyn C, Maralani P, Ruschin M, Sahgal A, Soliman H. J Neurooncol. 2023 Mar;162(1):119-128. doi: 10.1007/s11060-023-04265-y. Epub 2023 Mar 13.

 

Gamma knife icon based hypofractionated stereotactic radiosurgery(GKI-HSRS) for brain metastases: impact of dose and volume.

Yan M, Holden L, Wang M, Soliman H, Myrehaug S, Tseng CL, Detsky J, Ruschin M, Tjong M, Atenafu EG, Das S, Lipsman N, Heyn C, Sahgal A, Husain Z. J Neurooncol. 2022 Sep;159(3):705-712. doi: 10.1007/s11060-022-04115-3. Epub 2022 Aug 24.

 

Conventionally fully fractionated Gamma Knife Icon re-irradiation of primary recurrent intracranial tumors: the first report indicating feasibility and safety.

Yan M, Holden L, Detsky J, Tseng CL, Soliman H, Myrehaug S, Husain Z, Das S, Yeboah C, Lipsman N, Ruschin M, Sahgal A.

Precision Radiation for Brain Metastases With a Focus on Hypofractionated Stereotactic Radiosurgery.

Shiue K, Sahgal A, Lo SS. Semin Radiat Oncol. 2023 Apr;33(2):114-128. doi: 10.1016/j.semradonc.2023.01.004.

Please like and subscribe to Rad Chat on your podcast library.

Our links:

Link Tree:https://linktr.ee/radchat 

Facebook:https://www.facebook.com/RadChatPodcast/ 

Instagram:https://www.instagram.com/rad__chat/ 

LinkedIn:https://uk.linkedin.com/company/radtalk 

Tik Tok:https://www.tiktok.com/@rad_chat 

Twitter:https://twitter.com/rad__chat?lang=en 

YouTube: https://www.youtube.com/@radchat2259

Music and jingle credits: Dr. Ben Potts and Adam Cooke.

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  

You must not use any images, audio, video, graphics or clips separately from their accompanying context.  

Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

What is Rad Chat?

Rad Chat is a forward-thinking global knowledge hub where healthcare professionals can advance their knowledge and expertise in radiotherapy and oncology by utilising the award winning, first therapeutic radiographer led oncology podcast and social media channels.

We're empowering healthcare professionals worldwide by providing free, CPD-accredited radiotherapy and oncology education, by sharing real-world experience, expert insights, best practice and patient perspectives, we're helping healthcare professionals’ advance cancer care and improve patient outcomes.